The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis

Journal of Clinical Rheumatology

Volumn 17, Issue 5, 2011, Pages 249-255

  Targońska Stȩpniak, Bozena ^a   Drelich Zbroja, Anna ^a   Majdan, Maria ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

atherosclerosis; cardiovascular disease; carotid intima media thickness; disease activity; rheumatoid arthritis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; CYSTATIN C;

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; INTIMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CASE-CONTROL STUDIES; CHOLESTEROL; CREATININE; CYSTATIN C; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA; TUNICA MEDIA;

EID: 80051785501     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3182290dbf     Document Type: Article

References (42)

1. Gabriel SE. Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis. 2008;67(suppl III):iii30-iii34.
2. Ku IA, Imboden JB, Hsue PY, et al. Rheumatoid arthritis. A model of systemic inflammation driving atherosclerosis. Circulation J. 2009;73:977-985.
3. Stamatelopoulos KS, Kitas GD, Papamichael CM, et al. Atherosclerosis i rheumatoid arthritis versus diabetes. A comparative study. Artrioscler Thromb Vasc Biol. 2009;29:1702-1708.
4. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. Endothelial dysfunction, carotid intima-media thickness and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum. 2008;38:67-70.
5. Gonzalez-Juanatey C, Llorca J, Martin J, et al. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2009;38:366-371.
6. Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46:1489-1497. (Pubitemid 34620194)
7. Ristic GG, Lepic T, Glisic B, et al. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. Rheumatology (Oxford). 2010;49:1076-1081.
8. Roman MJ, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006;144:249-256. (Pubitemid 46768207)
9. Georgiadis AN, Voulgari PV, Argyropoulou MI, et al. Early treatmen reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. Semin Arthritis Rheum. 2008;38:13-19.
10. Hannawi S, Haluska B, Marwick TH, et al. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther. 2007;9:R116.
11. del Rincón I, Williams K, Stern MP, et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum. 2003;48:1833-1840. (Pubitemid 36828677)
12. Schott LL, Kao AH, Cunningham A, et al. Do carotid artery diamete manifest early evidence of atherosclerosis in women with rheumatoid arthritis? J Womens Health (Larchmt). 2009;18:21-29.
13. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324. (Pubitemid 18091653)
14. Jourdan C, Wühl E, Litwin M, et al. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens. 2005;23:1707-1715. (Pubitemid 41233431)
15. Bui AL, Katz R, Kestenbaum B, et al. Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2009;53:389-398
16. Prevoo ML, vant't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44-48.
17. Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases. J Rheumatol. 2005;32:1432-1439. (Pubitemid 41113961)
18. Peters MJL, Symmons DPM, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69:325-331.
19. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
20. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470. (Pubitemid 29135798)
21. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145:237-247.
22. Veller MG, Fisher CM, Nicolaides AN, et al. Measurement of the ultrasonic intima-media complex thickness in normal subjects. J Vasc Surg. 1993;17:719-725. (Pubitemid 23124951)
23. Linssen GC, Bakker SJ, Voors AA, et al. N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. Eur Heart J. 2010;31:120-127.
24. Schneeberger EE, Citera G, Maldonado Cocco JA, et al. Factors associated with disability in patients with rheumatoid arthritis. J Clin Rheumatol. 2010;16:215-218.
25. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, et al. HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med. 2003;114:647-652. (Pubitemid 36703233)
26. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007;57:125-132.
27. Pieringer H, Schumacher S, Stuby U, et al. Augmentation index and large-artery remodeling in patients with longstanding rheumatoid arthritis compared with healthy controls. Semin Arthritis Rheum. 2009;39:163-169.
28. Gonzalez-Juanatey C, Llorca J, Testa A, et al. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore). 2003;82:407-413. (Pubitemid 37445043)
29. Pereira I, Laurindo I, Burlingame R, et al. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis. J Bone Spine. 2008;75:416-421.
30. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, et al. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 2007;57:1074-1080. (Pubitemid 47237336)
31. Rojas-Villarraga A, Ortega-Hernandez OD, Gomez LF, et al. Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis. Semin Arthritis Rheum. 2008;38:71-82.
32. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655-663. (Pubitemid 38364624)
33. Barbato E, Rubattu S, Bartunek J, et al. Human coronary atherosclerosis modulates cardiac natriuretic peptide release. Atherosclerosis. 2009;206:258-264.
34. Targońska-Stȩpniak B, Majdan M. Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis. Clin Rheumatol. 2011;30:61-69.
35. Daoussis D, Panoulas VF, Antonopoulos I, et al. Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69:517-521.
36. Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A, et al. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol. 2005;32:1219-1223. (Pubitemid 40995373)
37. Gerli R, Bartoloni Bocci E, Sherer Y, et al. Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:724-725. (Pubitemid 351571944)
38. Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, et al. Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum. 2006;55:150-153. (Pubitemid 43235141)
39. Ferrante A, Giardina AR, Ciccia F, et al. Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. Rheumatol Int. 2009;30:193-198.
40. Wållberg-Jonsson S, Ohman M, Rantapää-Dahlqvist S. Which factors are related to the presence of atherosclerosis in rheumatoid arthritis? Scand J Rheumatol. 2004;33:373-379. (Pubitemid 40006884)
41. Cansu B, Cansu DU, Kazifoǧlu T, et al. Disease-modifying antirheumatic drugs increase serum adiponectin levels in patients with rheumatoid arthritis. J Clin Rheumatol. 2011;17:14-17.
42. Targońska-Stepniak B, Dryglewska M, Majdan M. Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. Rheumatol Int. 2010;30:731-737.